Skip to content

Effects of a 10-Week High-Intensity Interval Training Programme on Biochemical and Hormonal Responses in Elite Female Futsal Players

Temporal Dynamics of Biochemical and Hormonal Responses to Interval Training in Elite Female Futsal Players: A 10-Week Longitudinal Analysis Across Menstrual Cycle Phases

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07773519
Enrollment
32
Registered
2026-08-19
Start date
2026-02-02
Completion date
2026-07-01
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Physiology, Female Athletes, High-Intensity Interval Training, Menstrual Cycle

Keywords

Female Futsal Players, Menstrual Cycle, High-Intensity Interval Training, Exercise Physiology, Women's Health, Physical Performance

Brief summary

This study aims to investigate the biochemical, hormonal, and physiological adaptations to a 10-week periodized high-intensity interval training (HIIT) programme in elite female futsal players. The study will examine changes in aerobic fitness, blood lactate kinetics, muscle damage biomarkers, inflammatory markers, and reproductive hormones throughout the intervention. In addition, the influence of menstrual cycle phases on these physiological responses will be evaluated to improve understanding of sex-specific training adaptations and recovery. The findings are expected to contribute to evidence-based, individualized training and recovery strategies for female futsal athletes.

Detailed description

Female futsal is a high-intensity intermittent team sport requiring substantial aerobic and anaerobic fitness. Despite increasing participation of women in competitive sports, limited evidence exists regarding the biochemical and hormonal adaptations to structured interval training, particularly across different menstrual cycle phases. This prospective longitudinal study will recruit 32 elite female futsal players who will participate in a supervised 10-week periodized HIIT programme consisting of lactate threshold training, anaerobic intensification, and sport-specific interval training. Physiological assessments will include VO₂max, lactate threshold, blood lactate kinetics, creatine kinase, interleukin-6, C-reactive protein, cortisol, and reproductive hormones. Menstrual cycle phases will be monitored using validated menstrual tracking methods and hormonal confirmation. Outcomes will be assessed repeatedly throughout the intervention to determine temporal adaptations and the influence of menstrual cycle phase on training responses and recovery. The results are expected to support individualized, evidence-based training prescription for female athletes.

Interventions

BEHAVIORALRepeated Futsal Performance Testing Across Menstrual Cycle Phases Intervention Description Participants will undergo standardized futsal-specific performance assessments during different phases of the

Female futsal players will undergo standardized physical performance testing during different phases of the menstrual cycle. Assessments include agility, sprint speed, repeated sprint ability, explosive power, balance, and aerobic fitness. The study involves repeated performance assessments only, and no drug, device, surgical procedure, or therapeutic intervention will be administered.

Sponsors

Soran University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Different phases of mensuration was studies

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Female futsal players aged 18-30 years. * Regular menstrual cycles. * Participants willing to complete all scheduled testing sessions across the study period. * Participants able to safely participate in the prescribed physical-performance testing and training programme.

Exclusion criteria

* Pregnancy or breastfeeding. * Irregular menstrual cycles or diagnosed menstrual disorders. * Use of hormonal contraceptives or hormone therapy within the past 6 months. * Current musculoskeletal injury or any medical condition affecting physical performance. * Use of medications known to influence menstrual function, hormonal responses, or physical performance. * Use of performance-enhancing drugs or medications known to influence hormonal or biochemical responses. * History of endocrine, cardiovascular, or metabolic disorders. * Failure to complete all scheduled testing sessions.

Design outcomes

Primary

MeasureTime frameDescription
Mean Change from Baseline in Maximum Oxygen Uptake (VO₂max)Baseline and Week 10Maximum oxygen uptake (VO₂max) measured during a graded incremental treadmill exercise test with respiratory gas analysis. Unit of Measure: mL·kg-¹·min-¹.
Mean Change from Baseline in Velocity at VO₂max (vVO₂max)Baseline and Week 10Velocity at VO₂max (vVO₂max) measured during a graded incremental treadmill exercise test. Unit of Measure: km/h.
Mean Change from Baseline in Lactate Threshold VelocityBaseline and Week 10Lactate threshold velocity determined during incremental exercise testing. Lactate threshold velocity is defined as the running velocity corresponding to the lactate threshold. Unit of measure: km/h. Higher values indicate improved aerobic endurance.
Mean Change from Baseline in Resting Blood Lactate ConcentrationBaseline and Week 10Resting blood lactate concentration measured from venous blood samples collected under standardized resting conditions before exercise. Unit of Measure: mmol/L. Lower concentrations indicate improved metabolic efficiency.
Mean Change from Baseline in Lactate Clearance RateBaseline and Week 10Lactate clearance rate calculated as the rate of decline in blood lactate concentration from serial post-exercise measurements obtained during standardized recovery. The calculated clearance rate is reported as one value in mmol/L/min. Higher clearance rates indicate improved metabolic recovery.

Secondary

MeasureTime frameDescription
Serum Creatine Kinase (CK) Concentration at Predefined Recovery Time PointsBaseline; immediately post-exercise; 24 hours; 48 hours; and 72 hoursSerum creatine kinase concentration measured at baseline and predefined post-exercise recovery time points. Repeated CK concentrations are evaluated across the predefined sampling time points. Unit of Measure: U/L.
Interleukin-6 (IL-6)Baseline; immediately post-exercise; and recovery periodSerum interleukin-6 concentration measured as an indicator of exercise-induced inflammatory response. Unit of Measure: pg/mL. Lower resting concentrations and appropriate acute exercise responses indicate improved inflammatory regulation.
Serum CortisolBaseline; menstrual phase-specific assessments; and Week 10Serum cortisol concentration measured to evaluate physiological stress responses associated with high-intensity interval training. Unit of Measure: µg/dL.
Serum EstradiolPhase-specific assessments during the interventionSerum estradiol concentration measured to characterize hormonal status during different phases of the menstrual cycle. Unit of Measure: pg/mL.
Serum ProgesteronePhase-specific assessments during the interventionSerum progesterone concentration measured to confirm menstrual cycle phase and evaluate hormonal responses during the intervention. Unit of Measure: ng/mL.

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026